Robinhood To Rally Around 29%? Here Are 10 Top Analyst Forecasts For Thursday
Portfolio Pulse from Avi Kapoor
Top Wall Street analysts have updated their outlooks on several major stocks. Notable changes include price target adjustments and rating changes for Lumentum Holdings, The Progressive Corporation, Century Therapeutics, Snowflake Inc., Cisco Systems, The Allstate Corporation, Medtronic plc, Dell Technologies, Cardinal Health, and Robinhood Markets.
August 15, 2024 | 12:11 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Goldman Sachs increased The Allstate Corporation's price target from $199 to $204, maintaining a Buy rating. Shares gained 5.2% to $180.95.
The increased price target and maintained Buy rating indicate strong performance expectations, likely to positively impact the stock.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Baird boosted Cardinal Health's price target from $130 to $137, maintaining an Outperform rating. Shares rose 3.7% to $106.36.
The increased price target and maintained Outperform rating indicate strong performance expectations, likely to positively impact the stock.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Deutsche Bank boosted Robinhood Markets' price target from $21 to $24, upgrading the stock from Hold to Buy. Shares gained 1.3% to $18.65.
The increased price target and upgrade to Buy suggest positive sentiment, likely to boost investor confidence and the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Rosenblatt raised the price target for Lumentum Holdings from $65 to $69, maintaining a Buy rating. Shares fell 1.5% to $45.53.
The raised price target and maintained Buy rating suggest positive sentiment, likely to boost investor confidence despite the recent price drop.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Piper Sandler increased the price target for The Progressive Corporation from $250 to $252, maintaining an Overweight rating. Shares gained 5.4% to $234.34.
The increased price target and maintained Overweight rating indicate strong performance expectations, likely to positively impact the stock.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEUTRAL IMPACT
Rosenblatt boosted Cisco Systems' price target from $56 to $58, maintaining a Neutral rating. Shares gained 0.2% to $45.44.
The slight increase in price target with a Neutral rating suggests limited short-term impact on the stock.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 80
NEUTRAL IMPACT
Citigroup cut Dell Technologies' price target from $170 to $155, maintaining a Buy rating. Shares gained 3% to $102.95.
The reduced price target with a maintained Buy rating suggests mixed sentiment, likely to have a neutral short-term impact.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 80
NEUTRAL IMPACT
UBS increased Medtronic plc's price target from $76 to $90, upgrading the stock from Sell to Neutral. Shares fell 0.6% to $81.74.
The upgrade from Sell to Neutral and increased price target suggest improved outlook, but the immediate impact may be limited.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 80
NEGATIVE IMPACT
HC Wainwright & Co. cut Century Therapeutics' price target from $11 to $9, maintaining a Buy rating. Shares fell 5.5% to $1.56.
The reduced price target despite a Buy rating suggests caution, likely to negatively impact investor sentiment and the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Wells Fargo cut the price target for Snowflake Inc. from $200 to $130, downgrading the stock from Overweight to Equal-Weight. Shares gained 0.2% to $127.30.
The significant price target cut and downgrade suggest reduced growth expectations, likely to negatively impact the stock.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80